A recent study by researchers at the University of California, San Francisco (UCSF) has uncovered promising results from using psilocybin—the active ingredient in “magic mushrooms”—to ...

PSILOCYBIN therapy was found to be safe and well-tolerated in people with Parkinson’s disease and mood dysfunction, with clinically significant and sustained improvements in mood, cognition, and motor ...

A new study has found that psilocybin, the psychedelic ingredient in magic mushrooms, could be an effective treatment because of its brain-healing properties. Other than “waiting and seeing ...

Psilocybin, a natural compound found in certain mushrooms, has shown promise in treating depression and anxiety. UC San Francisco researchers wanted to know if it could be used to help Parkinson's ...

He is the author of books including Modern Architecture and Interiors (2006), editor of design magazine Dolce Vita and a contributor to titles including Wallpaper* and Frame, while also teaching at ...

Researchers found that psychedelics like psilocybin and MDMA may reduce fear by resetting brain-immune interactions, offering promising new avenues for treating depression and inflammatory diseases.

A series of exhibitions at No. 9 Cork Street, Frieze’s Mayfair gallery, presents work from an array of exciting contemporary makers. A group showcase curated by design gallery Béton Brut features ...

In 2019, the city of Denver became the first in the United States to decriminalize psilocybin, the hallucinogenic compound in so-called magic mushrooms. What began as a local experiment has now ...

Since 2019, the number of people in the United States using psilocybin has gone up sharply, which lines up with when some states began to decriminalize the hallucinogenic chemical found in ...

Psilocybin Use Dramatically Increasing In U.S. By Dennis Thompson HealthDay Reporter WEDNESDAY, April 23, 2025 (HealthDay News) — Recreational use of “magic mushroom” psilocybin skyrocketed ...

Psychedelic treatments like MDMA and psilocybin reduced fear in preclinical models and human tissue, potentially offering new treatment avenues for anxiety and depression by resetting immune-brain ...